Altre lingue VBI Vaccines Inc.

Azioni

VBIV

CA91822J2020

Mercato chiuso - Nasdaq Altri mercati azionari 22:00:00 30/04/2024			Variaz. 5gg	Var. 1 gen.
0,571 ^USD	+1,24%		-6,16%	-2,81%

16/04	VBI Vaccines Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI
03/04	VBI Vaccines Inc. presenta i dati incoraggianti della risposta tumorale precoce dello studio randomizzato e controllato di Fase 2b di VBI-1901 nel glioblastoma ricorrente	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

VBI Vaccines : 2023 Annual Report	17/04
VBI Vaccines Reports Full Year 2023 Financial Results	16/04
VBI Vaccines Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
North American Morning Briefing : Stock Futures -2-	15/04
VBI Vaccines Announces Closing of $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	11/04
VBI Vaccines Announces $2 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules	09/04
North American Morning Briefing : Inflation Data, -2-	08/04
VBI Vaccines Presents Encouraging Early Tumor Response Data From Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03/04
VBI Vaccines Inc. Presents Encouraging Early Tumor Response Data from Randomized Controlled Phase 2b Study of VBI-1901 in Recurrent Glioblastoma	03/04
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform - VBI Vaccines	03/04
VBI Vaccines Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA-Launched eVLP (MLE) Vaccine Platform	02/04
VBI Vaccines Inc. Announces Expanded Strategic Partnership with Canadian Government to Advance mRNA- Launched eVLP Vaccine Platform	02/04
Brii Biosciences Provides Corporate Update and Reports Full-Year 2023 Financial Results	25/03
North American Morning Briefing : Tech in Focus on -2-	25/03
North American Morning Briefing : Investors -2-	18/03
North American Morning Briefing : Stock Futures -2-	11/03
Brii Biosciences Announces Agreements To Acquire VBI Vaccines' IP Rights In BRII-179	05/03
Thinking about buying stock in Arena Group, Dunxin Financial Holdings, Nano-X Imaging, VBI Vaccines, or SuRo Capital?	15/02
VBI Vaccines Sells Rights to Hepatitis B Vaccine to Brii Biosciences	14/02
VBI Vaccines Inc. Enter into New License Agreement with Brii Biosciences	14/02

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue VBI Vaccines Inc.

Azioni

VBIV

CA91822J2020

Altre lingue

Filtri